SELLAS Life Sciences (SLS) Income from Discontinued Operations (2011 - 2017)
Powered by 
Analysis
SELLAS Life Sciences (SLS) Income from Discontinued Operations (2011 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | - |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | - |
| 10 | SELLAS Life Sciences | 2.66 Bn | 2.66 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 118,000.00 |
| Jun 30, 2017 | -1.30 Mn |
| Mar 31, 2017 | -9.44 Mn |
| Dec 31, 2016 | -3.58 Mn |
| Sep 30, 2016 | -2.59 Mn |
| Jun 30, 2016 | -2.89 Mn |
| Mar 31, 2016 | -3.39 Mn |
| Dec 31, 2015 | 41.02 Mn |
| Sep 30, 2015 | -11.67 Mn |
| Jun 30, 2015 | -2.19 Mn |
| Mar 31, 2015 | -2.23 Mn |
| Dec 31, 2014 | 14.96 Mn |
| Sep 30, 2014 | -2.64 Mn |
| Dec 31, 2013 | -5.35 Mn |
| Jun 30, 2012 | -423,000.00 |
| Mar 31, 2012 | -1.22 Mn |
| Dec 31, 2011 | -2.18 Mn |
| Sep 30, 2011 | -1.64 Mn |
| Jun 30, 2011 | -2.16 Mn |